• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Aerospace medicine and human performance. >Continuous Glucose Monitoring for In-Flight Measurement of Glucose Levels of Insulin-Treated Pilots
【24h】

Continuous Glucose Monitoring for In-Flight Measurement of Glucose Levels of Insulin-Treated Pilots

机译：连续葡萄糖监测飞行测量血糖水平来飞行员

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Due to the risk of hypoglycemia-related incapacitation, diabetic pilots requiring insulin are assessed as unfit according to the International Civil Aviation Organization and most national authorities. Some authorities, such as those from Canada, the United Kingdom, and the United States, permit selected insulin-treated pilots (ITDM-pilots) to fly subject to a protocol requiring pre-and in-flight capillary glucose measurements to show safe levels (> 100=< 300 mg . dl(-1)). Critics of such permission question the practicability of these in-flight measurements and whether clinically desired glycemic targets can be achieved while keeping glucose levels in the safe range. Subcutaneous continuous glucose monitoring (CGM) has recently been approved by the FDA as a stand-alone method to provide accurate glucose levels and treatment decision guidance in patients. This commentary considers that use of CGM by ITDM pilots facilitates practicability and recording of in-flight glucose measurements and facilitates achievement of clinically desired glycemic targets without increasing hypoglycemia risks.
机译：由于hypoglycemia-related的风险无能力,糖尿病飞行员需要胰岛素被评估为不显示国际民航组织大多数国家当局。那些来自加拿大、英国、和美国,允许选择来飞行员飞行(ITDM-pilots)协议要求和动态毛细管葡萄糖测量显示安全水平(> 100 = < 300毫克。这些飞行的实用性测量和临床是否满意血糖目标可以同时实现血糖水平在安全范围内。最近连续葡萄糖监测(CGM)被FDA批准的作为一个独立的方法提供准确的血糖水平和治疗指导病人的决定。认为使用CGM ITDM飞行员促进的实用性和记录动态血糖测量和便利实现临床所需的血糖目标不增加低血糖的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号